Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of acne vulgaris~* Willing to avoid excessive or prolonged exposure to ultraviolet light (eg, sunlight, tanning beds) throughout the study~Exclusion Criteria:~* Severe cystic acne, acne conglobata, acne fulminans, or secondary acne~* Use of phototherapy devices (eg, ClearLight™), energy-based devices, adhesive cleansing strips (eg, Pond's®, Biore®), or cosmetic procedures (eg, facials, peeling, comedo extraction) in the past week~* Use of anti-inflammatory medications, salicylic acid; corticosteroids, antibiotics, antibacterials (including benzoyl peroxide-containing products \[eg, benzamycin\]), retinoids; other topical acne treatments (eg, photodynamic therapy, medicated soaps such as those containing benzoyl peroxide, salicylic acid, sulfur, or sodium sulfacetamide) in the past 2 weeks~* Use of birth control pills strictly for acne control

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dapsone Gel (Type: EXPERIMENTAL): Dapsone gel applied topically to the face and to affected areas of the trunk once daily for 12 weeks.
- Dapsone Gel Vehicle (Type: PLACEBO_COMPARATOR): Dapsone gel vehicle applied topically to the face and to affected areas of the trunk once daily for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).